Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Alexander Revzin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8737-3250; OpenAlex author ID A5015961302; NIH RePORTER profile ID 7099279. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
1
Labs led
1
Collaborators
16
Papers, trials and grants by year

2021: 1 grant · 2022: none · 2023: none · 2024: 2 papers

Papers 2

  1. Microfluidic Organoid Cultures Derived from Pancreatic Cancer Biopsies for Personalized Testing of Chemotherapy and Immunotherapy. Last author DOI 10.1002/advs.202303088↗
  2. Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers16101861↗

Grants 1

  1. A microfluidic cell culture platform for personalizing pancreatic cancer therapies R21CA236612↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daheui Choi · 2 shared papers, 2024 · strength 0.35
  2. Wen Wee Ma · 2 shared papers, 2024 · strength 0.35
  3. Jeffrey S. Miller · 1 shared paper, 2024 · strength 0.18
  4. Daniel D. Billadeau · 1 shared paper, 2024 · strength 0.18
  5. Thorvardur Ragnar Halfdanarson · 1 shared paper, 2024 · strength 0.17
  6. Sani Haider Kizilbash · 1 shared paper, 2024 · strength 0.17
  7. Daniel H. Ahn · 1 shared paper, 2024 · strength 0.17
  8. Aakash P. Desai · 1 shared paper, 2024 · strength 0.17
  9. Alex A. Adjei · 1 shared paper, 2024 · strength 0.17
  10. Aaron Scott Mansfield · 1 shared paper, 2024 · strength 0.17
  11. Hani M. Babiker · 1 shared paper, 2024 · strength 0.17
  12. Steven R. Alberts · 1 shared paper, 2024 · strength 0.17
  13. Ryan Michael Carr · 1 shared paper, 2024 · strength 0.17
  14. Tanios Bekaii‐Saab · 1 shared paper, 2024 · strength 0.17
  15. Robert R. McWilliams · 1 shared paper, 2024 · strength 0.17
  16. Amit Mahipal · 1 shared paper, 2024 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.